|
Bionik Laboratories Corp (BNKL) |
|
Bionik Laboratories Corp
BNKL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Bionik Laboratories growth rates, revenue grew
by 158.15 % in the fourth quarter of 2023 from the same quarter a year ago.
Ranking at No. 205
Medical Equipment & Supplies industry recorded
growth of revenues by 3.48 %
Bionik Laboratories faced net loss in contrast to the net income a year ago in fourth quarter of 2023
• More on BNKL's Growth
|
|
Bionik Laboratories realized a net loss in trailing twelve months.
Bionik Laboratories realized cash reduction of $ -0.23 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.91.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.06.
• More on BNKL's Valuation
|
|
|
|
|
Bionik Laboratories realized net loss in trailing twelve months.
Bionik Laboratories realized cash outflow of $ -0.23per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.91.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.06.
• More on BNKL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com